Antibody therapy of cancer Journal Article
| Authors: | Scott, A. M.; Wolchok, J. D.; Old, L. J. |
| Article Title: | Antibody therapy of cancer |
| Abstract: | The use of monoclonal antibodies (mAbs) for cancer therapy has achieved considerable success in recent years. Antibody-drug conjugates are powerful new treatment options for lymphomas and solid tumours, and immunomodulatory antibodies have also recently achieved remarkable clinical success. The development of therapeutic antibodies requires a deep understanding of cancer serology, protein-engineering techniques, mechanisms of action and resistance, and the interplay between the immune system and cancer cells. This Review outlines the fundamental strategies that are required to develop antibody therapies for cancer patients through iterative approaches to target and antibody selection, extending from preclinical studies to human trials. © 2012 Macmillan Publishers Limited. All rights reserved. |
| Journal Title: | Nature Reviews Cancer |
| Volume: | 12 |
| Issue: | 4 |
| ISSN: | 1474-175X |
| Publisher: | Nature Publishing Group |
| Date Published: | 2012-03-22 |
| Start Page: | 278 |
| End Page: | 287 |
| Language: | English |
| DOI: | 10.1038/nrc3236 |
| PROVIDER: | scopus |
| PUBMED: | 22437872 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 April 2012" - "CODEN: NRCAC" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work